Patent Information

(54) Name
USE OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN COMBINATION WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND DOXORUBICINE FOR TREATING NON-HODGKIN' S LYMPHOMAS
(21) Filing number
PT34055
(21) EP Number
2268310 (open in ep register)
(51) Classification
N/A
Supplementary Protection
N/A
(22) Application date
15/12/2016
(24) Registration date
21/04/2017
Expiry date
23/03/2027  Renew
Status
Registered  
Protection period
18

Priority Details

N/A

Applicant Details

    (731) Name / Company Address State Town Post code Country
    Roche Glycart AG Wagistrasse 18 Schlieren-Zuerich 8952 Switzerland

Inventor Details

N/A

Representative Details

    (731) Name / Company Address State Town Post code Country
    Saba & Co IP CYPRUS P.O. Box 21143 Nicosia 1502 Cyprus

Address of Service 

    (731) Name / Company Address State Town Post code Country
    Dr. Luigi A. Sansone SALOMONE SANSONE 84-85, Melita Street Valletta VLT 1120 Malta

All Documents

N/A